$RGBP Regen BioPharma Issues End of Fiscal Year Shareholder Letter Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) President Dr. Harry Lander issued the following fiscal year end shareholder letter: As the end of Regen's fiscal year 2017 approaches on September 30th, I would like to summarize our progress during the past twelve months and look to the future. The Marketplace: http://www.prnewswire.com/…/regen-biopharma-issues-end-of-f…
ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.